Figure 5. Depletion of alveolar macrophages impairs the protective activity of passively-transferred immune sera against BA.5 infection.
(a) Scheme for depletion of neutrophils and monocytes, passive transfer of immune sera, and BA.5 challenge. Wild-type C57BL/6 twelve-week-old male mice were administered 500 μg of anti-Gr-1 (Ly6C/Ly6G) or isotype control antibody at Day −3 and −1 by intraperitoneal injection. On Day −1, mice were also given 60 μL of naïve or immune sera by intraperitoneal injection. On Day 0, mice were inoculated with 104 FFU of BA.5, and tissues were harvested for virological analysis on Day +3. (b-d) Analysis of depletion of immune cell subsets in blood of mice receiving anti-Gr-1 (Ly6C/Ly6G) or isotype antibody at 3 dpi. Summary of different cell types (b) based on the gating strategy (see Extended Data Fig 5a). Results are from two experiments (n = 6–10 mice per group; Mann-Whitney test with Bonferroni post-test correction, ns, not significant; **P < 0.01, ***P < 0.001****P < 0.0001). Representative flow cytometry dot plots showing depletion of neutrophils (c) and monocytes (d) with numbers indicating the cell population as a percentage of CD45+ cells. (e-f) Analysis of infectious viral burden by plaque assay at 3 dpi in nasal turbinates (e) and lungs (f) after BA.5 challenge (two experiments, n = 6–10 mice per group; Mann-Whitney test, ns, not significant). (g) Scheme for depletion of alveolar macrophages, passive transfer of immune sera, and BA.5 challenge. Wild-type C57BL/6 twelve-week-old male mice were administered control or clodronate liposomes at Day −3 by an intranasal route. On Day −1, mice were given 60 μL of naïve or immune sera by intraperitoneal injection. On Day 0, mice were inoculated with 104 FFU of BA.5, and tissues were harvested on Day +3. (h) Analysis of depletion of immune cell subsets in lungs of mice receiving liposomes at 3 dpi. Summary of different cell types (h) based on gating strategy (see Extended Data Fig 5b). Results are from two experiments (n = 7–12 mice per group; Mann-Whitney test with Bonferroni post-test correction, ns, not significant; **P < 0.01, ***P < 0.001, ****P < 0.0001). (i) Representative flow cytometry dot plots showing depletion of alveolar macrophages after liposome administration with numbers indicating the cell population as a percentage of CD45+ cells. (j-k) Analysis of infectious viral burden by plaque assay at 3 dpi in nasal turbinates (j) and lungs (k) after BA.5 challenge (two experiments, n = 7–12 mice per group; Mann-Whitney test, ns, not significant; ****P < 0.0001).
